ArticleCancers2024

Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.

Francesca Romana Mauro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.